開発段階から製造スケールへのバイオ医薬品プロセス移管を迅速かつ低リスクで実現するアプローチ

This article published in BioProcess International describes a scale-up approach that enables faster and more cost-effective manufacture of biologics in fed-batch cultures. It highlights a scaling methodology with a range of single-use bioreactors (15mL to 200L) from process development with Ambr^® bioreactors, through to pilot & manufacturing with Biostat^® STR bioreactors.